 
 
20 November 2025 
 
 
To,  
BSE  Limited 
Phiroze Jeejeebhoy Towers,  
Dalal Street, 
Mumbai - 400 001 
 
Scrip Code: 524669 
To,  
National Stock Exchange of India Limited 
Exchange Plaza,  
Bandra - Kurla Complex,  
Bandra (E), Mumbai - 400 051 
 
Symbol: HESTERBIO 
 
 
Dear Sir: 
 
Subject: Intimation under Regulation 30(5) of the SEBI (Listing Obligations and 
Disclosure Requirements) Regulations, 2015  
 
Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015 (“Listing Regulations”) read with the Company’s “Policy on Determination of 
Materiality for disclosure of events or information” , we hereby inform you that the Board of Directors 
of the Company has approved the changes in the KMPs authorised for determining materiality for 
disclosure of events or information to stock exchanges, consequent to appointment of Mr. Ashish Desai 
as a Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). 
 
The contact details of these KMPs authorised under Regulation 30(5) of the Listing Regulations are 
given below:- 
 
Sr. Name Designation 
1 Mr. Rajiv Gandhi CEO & Managing Director 
2 Ms. Priya Gandhi Executive Director 
3 Mr. Ashish Desai Chief Financial Officer 
4 Mr. Vinod Mali Company Secretary & Compliance Officer 
 
A single point of contact for the aforesaid Regulation 30(5) is given below:  
 
Mr. Vinod Mali  
Company Secretary & Compliance Officer  
Village Meda Adraj, Taluka Kadi,  
District Mehsana, Gujarat 384441, India 
Telephone: +91 79 2644 5106  
E-mail: cs@hester.in  
 
The aforesaid information is also being disclosed on the website of the Company www.hester.in. 
 
You are requested to take the above information on your record. 
 
 
Sincerely, 
For Hester Biosciences Limited 
 
 
 
Vinod Mali 
Company Secretary & Compliance Officer 
 
